Bifidobacterium breve CCFM1078 alleviates DNFB-induced atopic dermatitis in early-life via AhR activation, Th1/Th2 immune modulation, and gut microbiota regulation
Food & Function · 2026 · 17 (6) · 2927-2941
DOI: 10.1039/d5fo05688h ↗Kurz gefasst
Fachartikel in der Zeitschrift Food & Function, 2026. Verfasst von Yongqi Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi 214122, China. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Bifidobacterium breve, Th2 Cells, Th1 Cells. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 80 Literaturangaben. Gefördert von: Jiangnan University, Collaborative Innovationcenter of Food Safety and Quality Control in Jiangsu Province, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Early-life B. breve CCFM1078 alleviates DNFB-induced AD via gut-skin axis: remodels gut microbiota, elevates colonic IgA/sIgA; activates skin AhR pathway and inhibits TSLP; restores Th1/Th2 balance and reduces mast cell infiltration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi 214122, China.
- School of Food Science and Technology, Jiangnan University, Wuxi 214122, China.
- International Joint Research Laboratory for Maternal-Infant Microbiota and Health, Jiangnan University, Wuxi 214122, China.
- APC Microbiome Ireland, University College Cork, T12 K8AF Cork, Ireland.
- Teagasc Food Research Centre, Moorepark, Fermoy, P61 C996 Cork, Ireland.
- National Engineering Research Center for Functional Food, Jiangnan University, Wuxi 214122, China.
Förderung
- Jiangnan University
- Collaborative Innovationcenter of Food Safety and Quality Control in Jiangsu Province
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Li, Y., Li, H., Zhang, Q., Cui, S., Zhai, Q., Stanton, C., Ross, P., Zhao, J., Chen, W., & Yang, B. (2026). Bifidobacterium breve CCFM1078 alleviates DNFB-induced atopic dermatitis in early-life via AhR activation, Th1/Th2 immune modulation, and gut microbiota regulation. Food & Function, 17(6), 2927-2941. https://doi.org/10.1039/d5fo05688h
Vancouver
Li Y, Li H, Zhang Q, Cui S, Zhai Q, Stanton C, et al. Bifidobacterium breve CCFM1078 alleviates DNFB-induced atopic dermatitis in early-life via AhR activation, Th1/Th2 immune modulation, and gut microbiota regulation. Food & Function. 2026;17(6):2927-2941. doi:10.1039/d5fo05688h
BibTeX
@article{Li2026,
author = {Li, Yongqi and Li, Huizhen and Zhang, Qing and Cui, Shumao and Zhai, Qixiao and Stanton, Catherine and Ross, Paul and Zhao, Jianxin and Chen, Wei and Yang, Bo},
title = {Bifidobacterium breve CCFM1078 alleviates DNFB-induced atopic dermatitis in early-life via AhR activation, Th1/Th2 immune modulation, and gut microbiota regulation},
journal = {Food & Function},
year = {2026},
volume = {17},
number = {6},
pages = {2927--2941},
doi = {10.1039/d5fo05688h}
}
EUVIMED